H�kan Mellstedt - Concepedia

Author

H�kan Mellstedt

Karolinska Institutet

Also Known As

H�kan Mellstedt, H�kan T. Mellstedt

Publications

383

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Sophiahemmet Hospital Karolinska University Hospital Uppsala University Hospital

About

H�kan Mellstedt is an author at Karolinska Institutet specializing in medicine, immunology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	320
2	Immunology	5	5	301
3	Pathology	4	4	246
4	Molecular Biology	1	1	19
5	Pharmacology	1	1	19

H�kan Mellstedt

Publications

371

Citations

H-Index

Page 1

	Year	Citations
A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes Staffan Paulie, Barbro Ehlin‐Henriksson, H�kan Mellstedt, Cancer Immunology Immunotherapy HistocompatibilityUrologyGenitourinary CancerImmunologyImmunoediting	1985	166
Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A) J. Shetye, Jan-Erik Fr�din, Birger Christensson, Cancer Immunology Immunotherapy Tumor BiologySurgical OncologyGastrointestinal OncologyMedicineImmunology	1988	59
Anti-idiotypic monoclonal antibody to a T-cell chronic lymphatic leukemia CarlHarald Janson, Mahmood Jeddi‐Tehrani, H�kan Mellstedt, Cancer Immunology Immunotherapy Lymphoid NeoplasiaAutoimmune DiseaseAnti-idiotypic Monoclonal AntibodyMalignant Blood DisorderImmunology	1989	55
T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma Jan Fagerberg, Qing Yi, Dulceaydee Gigliotti, International Journal of Cancer	1999	51
Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia Christer Paul, Magnus Bj�rkholm, I Christenson, Cancer Chemotherapy and Pharmacology Hematological MalignancyAcute Nonlymphoblastic LeukemiaMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder	1981	19
Functional HLA-DR T cell epitopes of CEA identified in patients with colorectal carcinoma immunized with the recombinant protein CEA Gustav Ullenhag, H�kan Mellstedt, Jan Fagerberg, Cancer Immunology Immunotherapy Cancer ImmunosurveillanceMedicineImmunologyColorectal CancerPathology	2004	11
T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody Szilvia Mosolits, Katja Markovic, Jan Fagerberg, Cancer Immunology Immunotherapy Anti-idiotypic AntibodyImmunologyPathologyImmunodominanceColorectal Cancer	2004	10

Page 1